These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 28978686)

  • 21. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
    Alessio GD; Côrtes DF; Machado de Assis GF; Júnior PA; Ferro EA; Antonelli LR; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
    J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymerase chain reaction reveals Trypanosoma cruzi infection suspected by serology in cutaneous and mucocutaneous leishmaniasis patients.
    Chiaramonte MG; Frank FM; Furer GM; Taranto NJ; Margni RA; Malchiodi EL
    Acta Trop; 1999 Apr; 72(3):295-308. PubMed ID: 10232785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives.
    Krettli AU
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():142-51. PubMed ID: 19753469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected children.
    Bua J; Volta BJ; Perrone AE; Scollo K; Velázquez EB; Ruiz AM; De Rissio AM; Cardoni RL
    PLoS Negl Trop Dis; 2013; 7(10):e2476. PubMed ID: 24147166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.
    Alvarez MG; Bertocchi GL; Cooley G; Albareda MC; Viotti R; Perez-Mazliah DE; Lococo B; Castro Eiro M; Laucella SA; Tarleton RL
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004657. PubMed ID: 27128444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reactivity of GST-SAPA antigen of Trypanosoma cruzi against sera from patients with Chagas disease and leishmaniasis].
    Gil J; Cimino R; López Quiroga I; Cajal S; Acosta N; Juarez M; Zacca R; Orellana V; Krolewiecki A; Diosque P; Nasser J
    Medicina (B Aires); 2011; 71(2):113-9. PubMed ID: 21550926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Elecsys Chagas Assay for Detection of Trypanosoma cruzi-Specific Antibodies in a Multicenter Study in Europe and Latin America.
    Flores-Chavez MD; Sambri V; Schottstedt V; Higuera-Escalante FA; Roessler D; Chaves M; Laengin T; Martinez A; Fleischer B
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29444836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted screening strategies to detect Trypanosoma cruzi infection in children.
    Levy MZ; Kawai V; Bowman NM; Waller LA; Cabrera L; Pinedo-Cancino VV; Seitz AE; Steurer FJ; Cornejo del Carpio JG; Cordova-Benzaquen E; Maguire JH; Gilman RH; Bern C
    PLoS Negl Trop Dis; 2007 Dec; 1(3):e103. PubMed ID: 18160979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
    Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A lineage-specific rapid diagnostic test (Chagas Sero K-SeT) identifies Brazilian Trypanosoma cruzi II/V/VI reservoir hosts among diverse mammalian orders.
    McClean MCW; Bhattacharyya T; Mertens P; Murphy N; Gilleman Q; Gustin Y; Zeippen N; Xavier SCC; Jansen AM; Miles MA
    PLoS One; 2020; 15(1):e0227828. PubMed ID: 31951634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immuno-enzymatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: a tool for epidemiological studies.
    Cimino RO; Rumi MM; Ragone P; Lauthier J; D'Amato AA; Quiroga IR; Gil JF; Cajal SP; Acosta N; Juárez M; Krolewiecki A; Orellana V; Zacca R; Marcipar I; Diosque P; Nasser JR
    Parasitology; 2011 Jul; 138(8):995-1002. PubMed ID: 21518468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis.
    Egüez KE; Alonso-Padilla J; Terán C; Chipana Z; García W; Torrico F; Gascon J; Lozano-Beltran DF; Pinazo MJ
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005501. PubMed ID: 28369081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severity of Chagasic Cardiomyopathy Is Associated With Response to a Novel Rapid Diagnostic Test for Trypanosoma cruzi TcII/V/VI.
    Bhattacharyya T; Messenger LA; Bern C; Mertens P; Gilleman Q; Zeippen N; Bremer Hinckel BC; Murphy N; Gilman RH; Miles MA;
    Clin Infect Dis; 2018 Aug; 67(4):519-524. PubMed ID: 29438471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization and Diagnostic Application of Trypanosoma cruzi Trypomastigote Excreted-Secreted Antigens Shed in Extracellular Vesicles Released from Infected Mammalian Cells.
    Bautista-López NL; Ndao M; Camargo FV; Nara T; Annoura T; Hardie DB; Borchers CH; Jardim A
    J Clin Microbiol; 2017 Mar; 55(3):744-758. PubMed ID: 27974541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of an enzyme-linked immunosorbent assay that utilizes the Tc13Tul antigen of Trypanosoma cruzi to monitor patients after treatment with benznidazole.
    Santamaría AL; De Rissio AM; Riarte A; Garavaglia PA; Bruballa AC; Rodríguez MA; Irazu LE; Ruiz AM; García GA
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):197-205. PubMed ID: 23537784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissimilar Trypanosoma cruzi genotype-specific serological profile assessed by Chagas-Flow ATE IgG1 upon benznidazole etiological treatment of chronic Chagas disease.
    Alessio GD; Silvestrini CMA; Elói-Santos SM; Gontijo ED; Sales Júnior PA; Vitelli-Avelar DM; Sathler-Avelar R; Wendling APB; Teixeira-Carvalho A; de Lana M; Martins-Filho OA
    PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012487. PubMed ID: 39269987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance of tests based on Trypanosoma cruzi excreted-secreted antigens in an endemic area for Chagas' disease in Bolivia.
    Zarate-Blades CR; Bladés N; Nascimento MS; da Silveira JF; Umezawa ES
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):229-32. PubMed ID: 17020793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal fetal transmission of Trypanosoma cruzi: a problem of public health little studied in Mexico.
    Cardoso EJ; Valdéz GC; Campos AC; de la Luz Sanchez R; Mendoza CR; Hernández AP; Ramírez MH; Habana JR; González EB; Matzumura PD; Carlier Y
    Exp Parasitol; 2012 Aug; 131(4):425-32. PubMed ID: 22683499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Trypanosoma-decay accelerating factor antibodies in mice and humans infected with Trypanosoma cruzi.
    Tambourgi DV; Cavinato RA; De Abreu CM; Peres BA; Kipnis TL
    Am J Trop Med Hyg; 1995 Jun; 52(6):516-20. PubMed ID: 7611557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
    Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
    J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.